journal article·2018-02-17Open access

An overview application of silver nanoparticles in inhibition of herpes simplex virus

Abolfazl Akbarzadeh, Leila Kafshdooz, Zohre Razban, Ali Dastranj Tbrizi, Shadi Rasoulpour, Rovshan Khalilov, Taras Kavetskyy, Siamak Saghfi, Aygun N. Nasibova, Sharif Kaamyabi, Taiebeh Kafshdooz

Abstract

Nanoscale particles and molecules are a potential different for the treatment of disease because they have distinctive biologic property based on their structure and size, which is different from traditional small-molecule drugs. The antimicrobial mechanisms of silver nanoparticles include the formation of free radicals damaging the bacterial membranes, interactions with DNA, adhesion to cell surface altering the membrane properties, and enzyme damage. In this review, we focus on applications of silver nanoparticles in inhibition of herpes simplex virus.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · COVID-19 Impact on Reproduction · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Stem Cell Research Center, Tabriz University of Medical Sciences

Joint Ukraine-Azerbaijan International Research and Education Center of Nanobiotechnology and Functional Nanosystems

Universal Scientific Education and Research Network (USERN)

Student Research Committee, Tabriz Azad University

Drug Applied Research Center, Tabriz University of Medical Sciences

Department of Chemistry, Isfahan University of Technology

Institute of Radiation Problems, National Academy of Sciences of Azerbaijan

Faculty of Biology, Department of Biophysics and Molecular Biology, Baku State University

The John Paul II Catholic University of Lublin

Department of Basic Science, Farhangian University

Biotechnology Research Center, Tabriz University of Medical Sciences

Funding

Tabriz University of Medical Sciences

References (51)

Show source-provided references
1. Lövestam G, Rauscher H, Roebben G, et al. Considerations on a definition of nanomaterial for regulatory purposes. Luxembourg; Publications Office; 2010.
2. 10.3109/21691401.2014.97180510.3109/21691401.2014.971805 ↗
3. 10.1007/s00253-013-5473-x10.1007/s00253-013-5473-x ↗
4. 10.1016/S1470-2045(06)70793-810.1016/S1470-2045(06)70793-8 ↗
5. 10.1021/nl034140t10.1021/nl034140t ↗
6. 10.1021/jp063826h10.1021/jp063826h ↗
7. 10.1126/science.281.5385.201610.1126/science.281.5385.2016 ↗
8. 10.1021/nl025519310.1021/nl0255193 ↗
9. 10.1006/mthe.2000.017410.1006/mthe.2000.0174 ↗
10. 10.1016/j.chembiol.2003.09.01110.1016/j.chembiol.2003.09.011 ↗
11. 10.3109/21691401.2014.98280210.3109/21691401.2014.982802 ↗
12. 10.1126/science.108875510.1126/science.1088755 ↗
13. 10.1021/ja00140a04010.1021/ja00140a040 ↗
14. Pacioni NL, Borsarelli CD, Rey V, et al. Synthetic routes for the preparation of silver nanoparticles. Silver nanoparticle applications. New York: Springer; 2015. p. 13–46.
15. 10.1016/j.amjmed.2006.03.01110.1016/j.amjmed.2006.03.011 ↗
16. 10.1166/jnn.2007.78510.1166/jnn.2007.785 ↗
17. 10.1016/j.tibtech.2010.07.00610.1016/j.tibtech.2010.07.006 ↗
18. 10.3390/molecules1610889410.3390/molecules16108894 ↗
19. Henderson DA. Principles and lessons from the smallpox eradication programme. Bull World Health Organ. 1987;65:535.
20. 10.2147/IJN.S5007010.2147/IJN.S50070 ↗
21. 10.2147/IJN.S5501510.2147/IJN.S55015 ↗
22. 10.1016/S0079-6468(08)70024-910.1016/S0079-6468(08)70024-9 ↗
23. 10.3109/21691401.2014.97180710.3109/21691401.2014.971807 ↗
24. 10.12968/bjon.2010.19.Sup5.7770710.12968/bjon.2010.19.Sup5.77707 ↗
25. 10.1016/j.watres.2011.11.03710.1016/j.watres.2011.11.037 ↗
26. 10.3109/21691401.2014.97180510.3109/21691401.2014.971805 ↗
27. 10.4238/2014.March.19.210.4238/2014.March.19.2 ↗
28. 10.3949/ccjm.79a.1108210.3949/ccjm.79a.11082 ↗
29. 10.1016/j.jviromet.2011.09.00310.1016/j.jviromet.2011.09.003 ↗
30. 10.1021/bc900215b10.1021/bc900215b ↗
31. 10.3109/21691401.2014.97670710.3109/21691401.2014.976707 ↗
32. 10.1016/j.jhin.2005.04.01510.1016/j.jhin.2005.04.015 ↗
33. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
34. 10.1016/j.jconrel.2010.03.02210.1016/j.jconrel.2010.03.022 ↗
35. 10.1016/j.biomaterials.2003.10.07810.1016/j.biomaterials.2003.10.078 ↗
36. 10.5185/amlett.2013.752310.5185/amlett.2013.7523 ↗
37. Khandelwal N, Kaur G, Kumara N, et al. Application of silver nanoparticles in viral inhibition: a new hope for antivirals. Dig J Nanomater Biostruct. 2014;9:175.
38. 10.1021/la103401z10.1021/la103401z ↗
39. 10.1371/journal.pone.010411310.1371/journal.pone.0104113 ↗
40. 10.1136/sti.75.6.37710.1136/sti.75.6.377 ↗
41. 10.1086/51460010.1086/514600 ↗
42. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes: J IHMF. 2004;11:24A–35A.
43. 10.1128/JVI.66.1.341-348.199210.1128/JVI.66.1.341-348.1992 ↗
44. 10.7326/0003-4819-98-6-95810.7326/0003-4819-98-6-958 ↗
45. 10.1097/01.aids.0000198081.09337.a710.1097/01.aids.0000198081.09337.a7 ↗
46. 10.3109/21691401.2014.99882610.3109/21691401.2014.998826 ↗
47. 10.1159/00013491710.1159/000134917 ↗
48. 10.1056/NEJMoa02164110.1056/NEJMoa021641 ↗
49. 10.3109/21691401.2015.102963310.3109/21691401.2015.1029633 ↗
50. 10.1089/hum.1998.9.15-217710.1089/hum.1998.9.15-2177 ↗
51. Gedanken A editor. Antibacterial antiviral and antibiofilms nanoparticles. 2010 3rd International Nanoelectronics Conference (INEC); 2010.10.1109/INEC.2010.5424858 ↗